Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis

Journal of Medicine

Volumn 34, Issue 1-6, 2003, Pages 121-137

  Avni, Yona ^a   Shirin, Haim ^a   Aeed, Hussein ^a   Matas, Zipora ^a   Shahmurov, Mark ^a,b   Birkenfeld, Shlomo ^a   Bruck, Rafael ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Blood ammonia; Cytochrome P4502E1; Fatty liver; Fulminant hepatic failure; Hepatic enzymes; Steatohepatitis; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; CHOLINE; CYTOCHROME P450 2E1; CYTOCHROME P450 4A; MALONALDEHYDE; METHIONINE; THIOACETAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; HYPERLIPIDEMIA; LIPID PEROXIDATION; LIVER FAILURE; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; STATISTICAL ANALYSIS; SURVIVAL RATE; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECT; HEPATITIS; LIVER; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CHOLINE; CYTOCHROME P-450 CYP2E1; FATTY LIVER; HEPATITIS; LIVER; MALE; METHIONINE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOACETAMIDE;

EID: 34548780799     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bacon BR, Farahvash MJ, Janney CG, Neuschwander - Tetri BA. (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109.
2. Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995; 22: 1399-1403.
3. Burt AD, MacSween RNM, Peters TJ, Simpson KJ. (1991) Non-alcoholic fatty liver: causes and complications. In: Oxford Textbook of Clinical Hepatology. Vol 2, ed 1. Edited by McIntyre N Oxford: Oxford University Press 865-871.
4. Chieli E, Malvaldi G. (1984) Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 31:41-52
5. CYP2E1 and CYP4A as mirosomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000 105:1067-1075.
6. Dai Y, Rashba-Step J, Cederbaum AL. (1993) Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and the production of reactive oxygen intermediates. Biochemistry 32: 6928-6937.
7. Day CP, James OFW. (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27: 1463-1466.
8. Day CP, James OFW. (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114:842-844.
9. Day CP, Yeaman SJ. (1994) The biochemistry of alcoholic fatty liver. Biochim Biophys Acta 1215: 33-48.
10. Diehl AM, Goodman Z, Ishak KG. (1998) Alcohol-like disease in nonalcoholics. Gastroenterology 95: 1056-1062.
11. Drenick EJ, Fisler J, Johnson D. (1982) Hepatic steatosis after intestinal bypass - prevention and reversal by metronidazole irrespective of protein-calorie malnutrition. Gastroenterology 82: 535-548
12. Favreau LV, Malchoff DM, Mole JE, Schenkman JB. (1987) Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM56) elevations in diabetes. J Biol Chem 262: 14319-14326.
13. Fromenty B, Berson A, Pessayre D. (1997) Micro-vesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 26 (Suppl. 1): 13-22.
14. Geller D. (1988) An improved rat model of hepatic encephalopathy due to fulminant hepatic failure: the role of supportive therapy. In: Advances in Ammonia Metabolism and Hepatic Encephalopathy. Edited by Soeters PB, Wilson JHP, Meijer AJ, Holm E. Amsterdam: Elsevier Science Publishers:213-217.
15. Hasumura Y, Teschke R, Lieber CS. (1974) Increased carbon tetrachloride hepatotoxicity and its metabolism, after chronic ethanol consumption. Gastroentrology 66: 415-422.
16. Hunter AL, Holscher MA, Neal RA. (1977) Thioactamid-inducd hepatic necrosis. Involvement of the mixed-function oxidase enzyme system. J. Pharmacol. Exp. Ther 200:439-448.
17. Ingelman - Sundberg M, Johansson I, Yin H , Terelius Y, Eliasson E, Clot P, Albano E. (1993) Ethanol-inducible cytochrome P4502E1: genetic polymorphism regulation and possible role in the etiology of alcohol-induced liver disease. Alcohol 10: 447-452.
18. Ingelman-Sundberg M, Ekstrom G, Tindberg N. (1988) Lipid peroxidation-dependent on ethanol-inducible cytochrome P 450 from rat- liver. Adv Biophys 77: 43-47.
19. Larsen FS, knudsen GM, Paulson OB, Vilstrup H. (1994) Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. J Hepatol 21:491-495.
20. Lee RG. (1989) Non-alcoholic steatohepatitis, A study of 49 patients. Hum Pathol 20: 594-598.
21. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. (1996) Acute and chronic hepatitic steatosis lead to in vitro lipid peroxidation in mice. J. Hepatol 24:200-208.
22. Lieber CS. (1994) Alcohol and the liver: 1994 update. Gastroenterology 106: 1085-1105.
23. Lu SC, Huang ZZ, Yang H, Tsukamoto H. (1999) Effect of thioacetamide on the hepatic expression of gamma-glutamylcysteine synthetase subunits in the rat. Toxicol Appl Pharmacol 159(3): 161-168.
24. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. (1999) Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413-1419.
25. McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. (1980) Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 244: 251-253.
26. Muller D,Sommer M, Kretzschmar M, Zimmermann T, Buko VU, Lukivskaya OJ, Dargel R. (1991) Lipid peroxidation in thioacetamide-induced macronodular rat liver cirrhosis. Toxicology 65: 199-203.
27. Niehaus WG, Samuelsson JR, Wills ED. (1969) Lipid peroxide formation in microsomes. Biochem J 113:315-341.
28. Paradis V, Kollinger M ,Fabre M, Holstege A , Poynard T, Bedossa P. (1997) In situ detection of lipid peroxidation by products in chronic liver diseases. Hepatology 26: 135-142.
29. Pinto HC, Felipe P , Baptista A, Fernandes A, Camilo E, Ramalho F, Moura MC. (1996) Hepatic steatosis and lipid peroxidation in human chronic liver diseases. [Abstract]. Hepatology 24: 311A.
30. Porter W.R., Neal R.A. (1978) Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab. Dispos 6:379-388.
31. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. (1990) The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 11: 74-80.
32. Raucy JL , Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. (1991) Induction of cytochrome P4502E1 in the obese overfed rat. Mol Pharmacol 39: 275-280.
33. Sherlock S. (1995) Alcoholic liver disease. Lancet 345: 227-229.
34. Takahashi T, Lasker JM, Rosman AS, Lieber CS. (1993) Induction of cytochrome P 4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 17: 236-245.
35. Teli MR, Day CP, Burt AD, Bennelt MK, James OFM. (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346: 987-990.
36. Teli MR, James OF, Burt AD, Benett MK, Day CP. (1995) The natural history of non-alcoholic fatty liver. Hepatology 22:1714-1719.
37. Wang PY, Kaneko T, Wang Y, Sato A. (1999) Acarbose alone or in combination with ethanol potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen in rats. Hepatology 29: 161-165.
38. Wang T, Shankar K, Ronis MJJ, Mehendale HM. (2000) Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. Pharm Exp Ther 294:473-479.
39. Wanless IR, Lentz JS. (1990) Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy-study with analysis of risk factors. Hepatology 12: 1106-1110.
40. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. (1998) Hepatic cytochrome P4502E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology 27: 128-133.
41. Weltman MD, Farrell GC, Liddle C. (1996) Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645-1653.
42. Yamakawa T, Tanaka S- I, Yamakawa Y, Kiuchi Y, Isoda F, Kawamoto S, Sokuda K (1995) Augmented production of tumor necrosis factor - alpha in obese mice. Immunol Immunopathol 75: 5-56.
43. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann, H, Roth E, Hortnagl H. (1989) Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 9: 595-601.